PE20121690A1 - Signatura transcripcional en la sangre de infecciones de mycobacterium tuberculosis activas versus latentes - Google Patents
Signatura transcripcional en la sangre de infecciones de mycobacterium tuberculosis activas versus latentesInfo
- Publication number
- PE20121690A1 PE20121690A1 PE2012000735A PE2012000735A PE20121690A1 PE 20121690 A1 PE20121690 A1 PE 20121690A1 PE 2012000735 A PE2012000735 A PE 2012000735A PE 2012000735 A PE2012000735 A PE 2012000735A PE 20121690 A1 PE20121690 A1 PE 20121690A1
- Authority
- PE
- Peru
- Prior art keywords
- blood
- infection
- latent tuberculosis
- tuberculosis mycobacterium
- active versus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
SE REFIERE A UN METODO PARA DETECTAR UNA INFECCION ACTIVA POR MYCOBACTERIUM TUBERCULOSIS QUE ESTA LATENTE Y ASINTOMATICA QUE COMPRENDE A) OBTENER UN CONJUNTO DE DATOS DE LA EXPRESION GENETICA DE PACIENTES CON UNA INFECCION LATENTE Y ASINTOMATICA POR MYCOBACTERIUM TUBERCULOSIS; B) CLASIFICAR EL CONJUNTO DE DATOS DE LA EXPRESION GENETICA OBTENIDO EN EL PASO (A) EN MODULOS GENETICOS ASOCIADOS CON UNA INFECCION POR MYCOBACTERIUM TUBERCULOSIS; C) COMPARAR EL CONJUNTO DE DATOS DE LA EXPRESION GENETICA DE UN PACIENTE NO CLASIFICADO CON LOS MODULOS GENETICOS DESCRITOS EN (B), EN DONDE UN INCREMENTO O DISMINUCION EN LA TOTALIDAD DE LA EXPRESION GENETICA INDICA UNA INFECCION ACTIVA POR MYCOBACTERIUM TUBERCULOSIS EN LUGAR DE UNA INFECCION LATENTE Y ASINTOMATICA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/628,148 US20110129817A1 (en) | 2009-11-30 | 2009-11-30 | Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20121690A1 true PE20121690A1 (es) | 2012-12-16 |
Family
ID=44067161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2012000735A PE20121690A1 (es) | 2009-11-30 | 2010-08-19 | Signatura transcripcional en la sangre de infecciones de mycobacterium tuberculosis activas versus latentes |
Country Status (19)
Country | Link |
---|---|
US (2) | US20110129817A1 (es) |
EP (1) | EP2519652A4 (es) |
JP (1) | JP2013511981A (es) |
KR (2) | KR20120107979A (es) |
CN (1) | CN102844444A (es) |
AP (1) | AP2012006346A0 (es) |
AR (1) | AR080570A1 (es) |
AU (1) | AU2010325179B2 (es) |
BR (1) | BR112012013029A2 (es) |
CA (1) | CA2782211A1 (es) |
CL (1) | CL2012001400A1 (es) |
EA (1) | EA201270650A1 (es) |
IL (1) | IL220016A0 (es) |
MX (1) | MX2012006031A (es) |
PE (1) | PE20121690A1 (es) |
SG (1) | SG10201407855WA (es) |
TW (1) | TW201131032A (es) |
WO (1) | WO2011066008A2 (es) |
ZA (1) | ZA201204806B (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2524966A1 (en) * | 2011-05-18 | 2012-11-21 | Rheinische Friedrich-Wilhelms-Universität Bonn | Molecular analysis of tuberculosis |
TWI458978B (zh) * | 2011-12-27 | 2014-11-01 | Chengchung Chou | 判別開放性或潛伏性結核菌感染之方法 |
WO2013138497A1 (en) * | 2012-03-13 | 2013-09-19 | Baylor Research Institute | Early detection of tuberculosis treatment response |
CA2867481A1 (en) | 2012-04-13 | 2013-10-17 | Somalogic, Inc. | Tuberculosis biomarkers and uses thereof |
GB201211158D0 (en) * | 2012-06-22 | 2012-08-08 | Univ Nottingham Trent | Biomarkers and uses thereof |
EP2914740B1 (en) * | 2012-10-30 | 2017-09-13 | Imperial Innovations Ltd | Method of detecting active tuberculosis in children in the presence of a co-morbidity |
US20150315643A1 (en) * | 2012-12-13 | 2015-11-05 | Baylor Research Institute | Blood transcriptional signatures of active pulmonary tuberculosis and sarcoidosis |
WO2014133855A1 (en) * | 2013-02-28 | 2014-09-04 | Caprion Proteomics Inc. | Tuberculosis biomarkers and uses thereof |
GB201315748D0 (en) | 2013-09-04 | 2013-10-16 | Imp Innovations Ltd | Biological methods and materials for use therein |
WO2015048098A1 (en) | 2013-09-24 | 2015-04-02 | Washington University | Diagnostic methods for infectious disease using endogenous gene expression |
WO2015159239A1 (en) * | 2014-04-15 | 2015-10-22 | Stellenbosch University | A method for diagnosing tuberculous meningitis |
CN103954755B (zh) * | 2014-04-30 | 2017-04-05 | 广东省结核病控制中心 | 一种结核分枝杆菌潜伏感染的诊断试剂盒 |
WO2015171552A2 (en) | 2014-05-05 | 2015-11-12 | Emory University | Methods of diagnosing and treating tuberculosis |
CA3001134A1 (en) * | 2015-10-14 | 2017-04-20 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for diagnosis of tuberculosis |
GB201519872D0 (en) * | 2015-11-11 | 2015-12-23 | Univ Cape Town And Ct For Infectious Disease Res | Biomarkers for prospective determination of risk for development of active tuberculosis |
GB2547034A (en) * | 2016-02-05 | 2017-08-09 | Imp Innovations Ltd | Biological methods and materials for use therein |
KR101888101B1 (ko) * | 2016-09-19 | 2018-08-14 | 충남대학교산학협력단 | Scotin 단백질의 과발현에 의하여 결핵균 생존 및 증식을 억제하는 방법 |
JP6306124B2 (ja) * | 2016-11-01 | 2018-04-04 | 国立大学法人高知大学 | 結核検査用バイオマーカー |
CN107653313B (zh) * | 2017-09-12 | 2021-07-09 | 首都医科大学附属北京胸科医院 | Retn和klk1在作为结核病检测标志物中的应用 |
US11443433B2 (en) * | 2018-02-10 | 2022-09-13 | The Trustees Of The University Of Pennsylvania | Quantification and staging of body-wide tissue composition and of abnormal states on medical images via automatic anatomy recognition |
GB201804019D0 (en) | 2018-03-13 | 2018-04-25 | Univ Cape Town | Method for predicting progression to active tuberculosis disease |
US11036779B2 (en) * | 2018-04-23 | 2021-06-15 | Verso Biosciences, Inc. | Data analytics systems and methods |
CN108828235A (zh) * | 2018-08-23 | 2018-11-16 | 中国人民解放军第三〇九医院 | Pglyrp1蛋白作为标志物在诊断活动性结核病中的应用 |
CN109061191B (zh) * | 2018-08-23 | 2021-08-24 | 中国人民解放军第三〇九医院 | S100p蛋白作为标志物在诊断活动性结核病中的应用 |
CN110286231A (zh) * | 2019-06-19 | 2019-09-27 | 中国人民解放军总医院第八医学中心 | 用于检测cd160蛋白的物质在制备用于诊断活动性结核病的产品中的应用 |
CN111304313A (zh) * | 2019-12-13 | 2020-06-19 | 南方医科大学 | 一种检测fpr1基因表达水平的试剂的应用 |
EP3868894A1 (en) * | 2020-02-21 | 2021-08-25 | Forschungszentrum Borstel, Leibniz Lungenzentrum | Method for diagnosis and treatment monitoring and individual therapy end decision in tuberculosis infection |
CN116994646B (zh) * | 2023-08-01 | 2024-06-11 | 东莞市滨海湾中心医院(东莞市太平人民医院、东莞市第五人民医院) | 一种菌阳活动性肺结核风险评估模型的构建方法与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6627198B2 (en) * | 1997-03-13 | 2003-09-30 | Corixa Corporation | Fusion proteins of Mycobacterium tuberculosis antigens and their uses |
US6713257B2 (en) * | 2000-08-25 | 2004-03-30 | Rosetta Inpharmatics Llc | Gene discovery using microarrays |
EP1425412A2 (en) * | 2000-11-28 | 2004-06-09 | University Of Cincinnati | Blood assessment of injury |
EP2196473A1 (en) * | 2001-07-04 | 2010-06-16 | Health Protection Agency | Mycobacterial antigens expressed during latency |
AU2003241055A1 (en) * | 2002-06-20 | 2004-01-06 | Glaxo Group Limited | Surrogate markers for the determination of the disease status of an individual infected by mycobacterium tuberculosis |
AU2009262112A1 (en) * | 2008-06-25 | 2009-12-30 | Baylor Research Institute | Blood transcriptional signature of mycobacterium tuberculosis infection |
-
2009
- 2009-11-30 US US12/628,148 patent/US20110129817A1/en not_active Abandoned
-
2010
- 2010-08-19 KR KR1020127017108A patent/KR20120107979A/ko active Application Filing
- 2010-08-19 EP EP10833713.0A patent/EP2519652A4/en not_active Withdrawn
- 2010-08-19 CA CA2782211A patent/CA2782211A1/en not_active Abandoned
- 2010-08-19 CN CN2010800627107A patent/CN102844444A/zh active Pending
- 2010-08-19 EA EA201270650A patent/EA201270650A1/ru unknown
- 2010-08-19 KR KR1020147014569A patent/KR20140078768A/ko not_active Application Discontinuation
- 2010-08-19 AU AU2010325179A patent/AU2010325179B2/en not_active Ceased
- 2010-08-19 WO PCT/US2010/046042 patent/WO2011066008A2/en active Application Filing
- 2010-08-19 JP JP2012541071A patent/JP2013511981A/ja not_active Ceased
- 2010-08-19 BR BR112012013029A patent/BR112012013029A2/pt not_active IP Right Cessation
- 2010-08-19 SG SG10201407855WA patent/SG10201407855WA/en unknown
- 2010-08-19 PE PE2012000735A patent/PE20121690A1/es not_active Application Discontinuation
- 2010-08-19 MX MX2012006031A patent/MX2012006031A/es not_active Application Discontinuation
- 2010-08-19 AP AP2012006346A patent/AP2012006346A0/xx unknown
- 2010-11-30 AR ARP100104425A patent/AR080570A1/es unknown
- 2010-11-30 TW TW099141689A patent/TW201131032A/zh unknown
-
2012
- 2012-05-24 IL IL220016A patent/IL220016A0/en unknown
- 2012-05-30 CL CL2012001400A patent/CL2012001400A1/es unknown
- 2012-06-27 ZA ZA2012/04806A patent/ZA201204806B/en unknown
-
2013
- 2013-09-11 US US14/024,142 patent/US20140080732A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2013511981A (ja) | 2013-04-11 |
KR20120107979A (ko) | 2012-10-04 |
AR080570A1 (es) | 2012-04-18 |
EP2519652A4 (en) | 2013-05-01 |
SG10201407855WA (en) | 2015-01-29 |
AP2012006346A0 (en) | 2012-06-30 |
IL220016A0 (en) | 2012-07-31 |
AU2010325179A1 (en) | 2012-07-05 |
EP2519652A2 (en) | 2012-11-07 |
US20140080732A1 (en) | 2014-03-20 |
TW201131032A (en) | 2011-09-16 |
MX2012006031A (es) | 2012-10-03 |
CL2012001400A1 (es) | 2014-05-09 |
WO2011066008A2 (en) | 2011-06-03 |
WO2011066008A3 (en) | 2011-07-21 |
BR112012013029A2 (pt) | 2016-10-04 |
ZA201204806B (en) | 2013-02-27 |
EA201270650A1 (ru) | 2013-06-28 |
CN102844444A (zh) | 2012-12-26 |
CA2782211A1 (en) | 2011-06-03 |
AU2010325179B2 (en) | 2015-03-12 |
KR20140078768A (ko) | 2014-06-25 |
US20110129817A1 (en) | 2011-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20121690A1 (es) | Signatura transcripcional en la sangre de infecciones de mycobacterium tuberculosis activas versus latentes | |
BR112017017876A2 (pt) | sensores de impressão digital para dispositivos móveis | |
BR112018012818A2 (pt) | adesivo de monitoramento de saúde | |
BR112014029588A2 (pt) | sistema e métodos para detectar distúrbios de saúde | |
EA201170088A1 (ru) | Транскрипционная сигнатура крови инфекции mycobacterium tuberculosis | |
DE602008001569D1 (de) | Optische Bildmessvorrichtung und Bildverarbeitungsvorrichtung | |
BR112016024187A2 (pt) | sistema sensor de fibra óptica, e, método para a determinação de uma localização de uma perturbação | |
ECSP13012431A (es) | Combinación del compuesto glyt1 con antipsicóticos | |
BR112012020251A2 (pt) | dispositivo de análise para a aquisição de amostra, tratamento e reação | |
ECSP13012394A (es) | Nuevas formas de dosificación de liberación modificada de un inhibidor de la xantina oxidorreductasa o de inhibidores de xantina oxidasa | |
BR112013010283A2 (pt) | método de calibração de um sensor de ar de um dispositivo de tratamento de ar, conjunto de instruções executáveis por computador e dispositivo de tratamento de ar | |
GT201200293A (es) | Marcadores predictivos útiles en el tratamiento del síndrome frágil x (fxs) | |
CL2012002542A1 (es) | Proceso in vitro para la determinación rápida del estado de infección de pacientes con infección por mycobacterium tuberculosis a partir de sangre entera en términos de tuberculosis activa o latente, que comprende las etapas de (i) estimular una célula t antígeno específico, y (ii) determinar un perfil de citosinas a partir de tanto la producción intracelular de inf-gamma como de il-2. | |
BR112014020113A8 (pt) | Composições farmacêuticas e método para diminuir a frequência de micção | |
BR112015031197A2 (pt) | sistema de medida de pressão discriminando uma pane de uma superpressão ou de depressão | |
CL2018001804A1 (es) | Uso de la carrimicina en la infección por micobacterium tuberculosis resistente | |
CL2008002299A1 (es) | Dispositivo para conservar y poner a disposicion obleas de medicamento que comprende bolsitas de medicamento dispuesta en una pila de bolsitas con obleas de medicamento, donde tanto en el dispositivo portador de las bolsitas asi como en la bolsa de medicamento estan dispuestas indicaciones temporales. | |
BR112014015037A2 (pt) | método, sistema e dispositivo eletrônico para determinar a trajetória de um fluxo aquoso, e sonda autônoma | |
BR112015027140A8 (pt) | Módulo de cálculo de bloqueio e método de cálculo de bloqueio | |
EP2538460A3 (en) | Light emitting device and light emitting device package | |
GB2520889A (en) | Patient reported outcome instrument | |
BR112017012118A2 (pt) | componente elétrico fácil de produzir e método para produzir um componente elétrico | |
CO6321268A2 (es) | Nifurtimox para el tratamiento de enfermedades causadas por trichomonadida | |
BR112013005518A2 (pt) | método para detectar anticorpos específicos de vírus em uma amostra, método para diagnosticar uma infecção viral, método para aumentar os baixos níveis de anticorpos antivirais em uma amostra de sangue complera e kit para a detecção de anticorpos especificos de vírus expressos em níveis baixos em um indivíduo | |
DOP2012000316A (es) | Metodo para diagnosticar una respuesta al tratamiento en sujetos con esclerosis multiple |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |